LCM
IMA

Laurion Capital Management’s ImageneBio Inc IMA Stock Holding History

Laurion Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,051
Closed -$734K – 567
2023
Q4 		$734K Sell
31,051
-13,504
-30% -$440K 0.01% 365
2023
Q3 		$2.32M Buy
44,555
+1,425
+3% +$85.8K 0.01% 326
2023
Q2 		$3.4M Sell
43,130
-953
-2% -$68.3K 0.02% 281
2023
Q1 		$1.83M Hold
44,083
– – 0.01% 278
2022
Q4 		$1.41M Hold
44,083
– – 0.01% 317
2022
Q3 		$1.88M Hold
44,083
– – 0.01% 331
2022
Q2 		$2.34M Buy
+44,083
New +$2.43M 0.04% 219

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurion Capital Management's IMA Position: Q1 2024 in Review

Laurion Capital Management sold out of ImageneBio Inc (IMA) in Q1 2024, closing a stake of 31,051 shares — an estimated $734K sold.

Laurion Capital Management first reported a position in IMA in Q2 2022 and held it in 7 quarters. The position peaked at $3.4M in Q2 2023. 55 funds tracked by Wall St. Rank hold IMA as of Q1 2024.

  • Laurion Capital Management reported no remaining ImageneBio Inc position as of Q1 2024 after selling out during the quarter.
  • Laurion Capital Management sold 31,051 ImageneBio Inc shares in Q1 2024, an estimated $734K.
  • Laurion Capital Management first reported a position in ImageneBio Inc in Q2 2022 and held it in 7 quarters.
  • Laurion Capital Management's ImageneBio Inc position peaked at $3.4M in Q2 2023.
  • 55 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2024.

Based on Laurion Capital Management's 13F filing for Q1 2024, filed 15 May 2024.